Court Allows Federal FCA Case Against Abbott to Proceed

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

By signing up for a tour of the Thompson FDA Compliance Expert Suite, you are also registering to receive email offers and product updates from us. Simply click unsubscribe at the bottom of any email if you would like to discontinue delivery.

Court Allows Federal FCA Case Against Abbott to Proceed

J.W. Schomisch

August 29, 2022 at 11:05 AM EST

A federal district court allowed a federal False Claims Act (FCA) case to continue against Abbott Laboratories over an alleged kickback scheme. However, the U.S. District Court for the Southern District of California did grant an Abbott motion to dismiss state FCA claims with leave to amend. The case stems from a whistleblower who was employed by Abbott from August 2015 to A... Read More

My Research Folders

You are not Logged in yet, Please login to see Your research folders.

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

Court Allows Federal FCA Case Against Abbott to Proceed

My Research Folders

THOMPSON FDA

COMPLIANCE EXPERT

RESOURCES

HELP

CONTACT